Excelsior Sciences

Excelsior Sciences is a company dedicated to developing novel chemical technologies, focusing on leveraging artificial intelligence and automated platforms to transform the discovery and manufacturing processes of small-molecule drugs. The company provides modular and automation-friendly carbon-carbon bond formation methods, combined with an AI-guided closed-loop learning and discovery system, enabling customers to accelerate drug development, reduce uncertainty in molecular design, strengthen the supply chain through localized automated production, and seamlessly scale from milligrams to kilograms with speed and certainty.